Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02785458 · ClinicalTrials.gov registry record · NA
Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 1,005
- Enrollment target
NCT02785458: Completed NA study, sponsored by Northwestern University.
NCT02785458 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 1,005 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02785458, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,005 participants
- Enrollment target
Study Summary
This study evaluates the effectiveness of an electronic health record based educational intervention (the EMC2 strategy) to improve patient understanding and use of higher-risk medications. Half of the participants will receive the intervention, while the other half will receive the usual amount of information (usual care).
Primary Outcome
Adjusted Least-square means of Medication Knowledge are calculated based on patient's ability to identify each medication's purpose and side effects, risks, warnings and benefits using general linear mixed models, specifying the identity link (PROC GLIMMIX). Treatment assignment by time is the independent variable of interest and modeled as a fixed effect, and clinic as a random effect, with additional subject statement to model correlations with patient. Confounding variables, such as age, pref
Interventions
- BEHAVIORAL EMC2 Strategy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,005 participants |
| Start Date | 2017-06-08 |
| Est. Completion | 2019-09-20 |
| Phase | NA |
What the finished NCT02785458 record still lists
NCT02785458 is an interventional study that assigns participants to a tested intervention. Its 1,005 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower).
The record links to 0 conditions, and to 1 intervention - of which EMC2 Strategy is the first listed.
NCT02785458 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02785458 about?
NCT02785458 is a clinical study titled "Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial". This study evaluates the effectiveness of an electronic health record based educational intervention (the EMC2 strategy) to improve patient understanding and use of higher-risk medications. Half of the participants will receive the intervention, while the other half will receive the usual amount of ...
What is the current status of trial NCT02785458?
This trial is currently completed. It is a NA study. The enrollment target is 1,005 participants. The study started on 2017-06-08. Estimated completion is 2019-09-20.
What interventions are being tested in trial NCT02785458?
The interventions under investigation include: EMC2 Strategy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02785458?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02785458's enrollment target sits among peer trials
1,005 106th of 2000 higher than 1,895 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT06207864 · 1,001 participants · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI